Oniria Therapeutics
Signal active
Organization
Contact Information
Overview
Onira Therapeutics is modifying cell dormancy to fight the persistence of cancer.
About
Industries
Biotechnology, Biopharma, Therapeutics
Founded
2021
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Oniria Therapeutics headquartered in Europe, operates in the Biotechnology, Biopharma, Therapeutics sector. The company focuses on Biotechnology and has secured $16.8M in funding across 12 round(s). With a team of 1-10 employees, Oniria Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Oniria Therapeutics, raised $1.4M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
5
Lead Investors
0
Total Funding Amount
$1.4M
Details
1
Oniria Therapeutics has raised a total of $1.4M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 1.4M |
Investors
Oniria Therapeutics is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Investigo | - | FUNDING ROUND - Investigo | 1.4M |
| Yolanda Perez Saez | - | FUNDING ROUND - Yolanda Perez Saez | 1.4M |
| Oniria Therapeutics | - | FUNDING ROUND - Oniria Therapeutics | 1.4M |
| BStartup | - | FUNDING ROUND - BStartup | 1.4M |
Recent Activity
There is no recent news or activity for this profile.